Clinical Oncology
Volume 19, Issue 9 , Pages 706-710, November 2007

External Beam Radiotherapy and High Dose Rate Brachytherapy for Medically Unfit and Elderly Patients

  • C.A.M. Marijnen

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: C. A. M. Marijnen, Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Tel: +31-20-5122124; Fax: +31-20-5122308.

Department of Radiotherapy, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Received 18 April 2007; accepted 26 July 2007.

Abstract 

In the treatment of rectal cancer, total mesorectal excision surgery is now the standard of care. In most patients, surgery will be preceeded by radiotherapy, either in a short course (25Gy/five fractions) or in a conventional schedule (45–50Gy/25 fractions) with chemotherapy.

For patients unfit for surgery or unwilling to undergo a procedure resulting in a permanent colostomy, radiotherapy without surgery is the alternative.

From published studies it is clear that for relatively small tumours, local treatment with either contact X-rays or intraluminal brachytherapy is a reasonable option. For patients with larger tumours, the risk of nodal involvement makes the combination of local radiotherapy with external beam radiotherapy necessary. So far, this combination has mainly been given with contact X-rays and only sporadically with intraluminal brachytherapy. In this overview, a summary of published studies will be given, with a proposal for a trial for medically unfit patients with T2–T4 tumours.

Key words: Brachytherapy, contact X-rays, local recurrence, radiotherapy, rectal cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0936-6555(07)00737-6

doi:10.1016/j.clon.2007.07.015

Clinical Oncology
Volume 19, Issue 9 , Pages 706-710, November 2007